LEADER 00968nam0-2200301 --450 001 9910745493303321 005 20231018114303.0 010 $a88-8498-250-2 020 $aIT$b2007-9036 100 $a20231018d2006----kmuy0itay5050 ba 101 0 $aita 102 $aIT 105 $a 001yy 200 1 $aArnaldo Momigliano nella storiografia del Novecento$fa cura di Leandro Polverini 210 $aRoma$cEdizioni di storia e letteratura$d2006 215 $a249 p.$d24 cm 225 1 $aStoria e letteratura$v224 300 $aAtti di un convegno tenuto a Spoleto nel 1999 610 0 $aMomigliano, Arnaldo$aAtti di congressi 676 $a930.07$v23$zita 702 1$aPolverini,$bLeandro 801 0$aIT$bUNINA$gREICAT$2UNIMARC 901 $aBK 912 $a9910745493303321 952 $aFONDO PROFESSOR ANTONIO GUARINO CONG. A 4$bG/1427$fFGBC 959 $aFGBC 996 $aArnaldo Momigliano nella storiografia del Novecento$92429310 997 $aUNINA LEADER 03408nam 2200577Ia 450 001 9910437834303321 005 20200520144314.0 010 $a94-007-6467-7 024 7 $a10.1007/978-94-007-6467-5 035 $a(CKB)2670000000372385 035 $a(EBL)1697553 035 $a(OCoLC)843401902 035 $a(SSID)ssj0000894263 035 $a(PQKBManifestationID)11932485 035 $a(PQKBTitleCode)TC0000894263 035 $a(PQKBWorkID)10834885 035 $a(PQKB)11223636 035 $a(DE-He213)978-94-007-6467-5 035 $a(MiAaPQ)EBC1697553 035 $a(PPN)170494764 035 $a(EXLCZ)992670000000372385 100 $a20130522d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAngiogenesis modulations in health and disease $epractical applications of pro-and anti-angiogenesis targets /$fShaker A. Mousa, Paul J. Davis, editors 205 $a1st ed. 2013. 210 $aDordrecht ;$aNew York $cSpringer$dc2013 215 $a1 online resource (209 p.) 300 $aDescription based upon print version of record. 311 $a94-017-8515-5 311 $a94-007-6466-9 320 $aIncludes bibliographical references and index. 327 $aPreface -- Angiogenesis assays: an appraisal of current techniques -- Survey of pro-angiogenesis strategies -- Angiogenesis modulation by arachidonic acid ? derived lipids: positive and negative regulators of angiogenesis -- Pro-angiogenic activity of thyroid hormone analogues: Mechanisms, physiology and clinical prospects -- Actions of steroids and peptide hormones on angiogenesis -- Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis modulation.-  Catecholamine neurotransmitters: an angiogenic switch in the tumor microenvironment -- Impact of nanotechnology on therapeutic angiogenesis -- Survey of anti-angiogenesis strategies -- Tetraiodothyroacetic acid (tetrac), nanotetrac and anti-Angiogenesis -- Integrin antagonists and angiogenesis -- Anti-angiogenesis therapy as an adjunct to chemotherapy in oncology -- Anti-vegf strategies in ocular angiogenesis- mediated disorders, with special emphasis on age-related macular degeneration -- Application of nanotechnology to targeting tumor angiogenesis for therapeutic benefit -- Biomarkers of response and resistance to anti-angiogenic treatment -- Speculations on new directions in which angiogenesis may proceed. Index. 330 $a This book is a major update of novel targets in angiogenesis modulation, including pro- and anti-angiogenesis. There is in-depth coverage of preclinical and clinical methods and models, investigational status, and clinical applications. The impact of nanotechnology in advancing the applications of pro-and anti-angiogenesis strategies is also highlighted, along with stem cell and biotechnologies in research and development of angiogenesis modulating targets. 606 $aNeovascularization 606 $aBlood vessels$xGrowth 615 0$aNeovascularization. 615 0$aBlood vessels$xGrowth. 676 $a610 701 $aMousa$b Shaker A$0556586 701 $aDavis$b Paul J$01763139 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910437834303321 996 $aAngiogenesis modulations in health and disease$94203427 997 $aUNINA